Home › Asset managers › Compare 2024-2025 › Vanguard vs Northern Trust
Vanguard 2024-2025 · Northern Trust 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 94,997 | 86,137 | 5,768 | 3,092 | 93.7% | 92.7% |
| Board proposals | 74,087 | 66,390 | 5,096 | 2,601 | 92.9% | 91.8% |
| E&S shareholder proposals | 258 | 94 | 37 | 127 | 71.8% | 60.7% |
| Other items | 20,652 | 19,653 | 635 | 364 | 96.9% | 96.2% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
5,768 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | Northern Trust |
|---|---|---|---|---|---|---|
| COMPANHIA PARANAENSE DE ENERGIA | April 24, 2025 | Elect Directors Director Elections |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| COMPANHIA SIDERURGICA NACIONAL | April 30, 2025 | Elect Directors Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| COMPANY FOR COOPERATIVE INSURANCE | May 27, 2025 | Authorize Share Repurchase Program Up to 199,862 Shares to be Allocated for Employees Stock Incentive program and Authorize Board to Execute All Related Matters Capital Structure |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| COMPASS INC. | May 22, 2025 | Election of Class I Directors: Frank Martell Director Elections |
Board | For | FOR 18 funds |
AGAINST 3 funds |
| COMPOSECURE INC. | May 28, 2025 | Election of Directors: John D. Cote Director Elections |
Board | For | FOR 11 funds |
WITHHOLD 1 fund |
| COMPUTACENTER PLC | May 15, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| COMPUTER AGE MANAGEMENT SERVICES LTD. | December 10, 2024 | Elect Dinesh Kumar Mehrotra as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| COMPX INTERNATIONAL INC. | May 21, 2025 | Director Nominees: Michael S. Simmons Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 2 funds |
| COMSYS HOLDINGS CORP. | June 27, 2025 | Elect Director Kagaya, Takashi Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COMSYS HOLDINGS CORP. | June 27, 2025 | Elect Director Tanabe, Hiroshi Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COMTECH TELECOMMUNICATIONS CORP. | January 13, 2025 | Election of Directors: Bruce T. Crawford Director Elections |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CONAGRA BRANDS INC. | September 18, 2024 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 4 funds |
| CONCRETE PUMPING HOLDINGS INC. | April 22, 2025 | To elect the four Class I Director nominees: David G. Hall Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 1 fund |
| CONDUIT PHARMACEUTICALS INC. | December 18, 2024 | Election of Directors: Faith L. Charles Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 1 fund |
| CONDUIT PHARMACEUTICALS INC. | December 18, 2024 | Election of Directors: Freda Lewis-Hall Director Elections |
Board | For | WITHHOLD 4 funds |
FOR 1 fund |
| CONSOLIDATED WATER CO. LTD. | May 27, 2025 | The election of eight directors to the Board of Directors: Leonard J. Sokolow Director Elections |
Board | For | FOR 5 funds |
WITHHOLD 3 funds |
| CONSTELLATION BRANDS INC. | July 17, 2024 | Election of Directors: Ernesto M. Hernandez Director Elections |
Board | For | FOR 22 funds |
AGAINST 3 funds |
| CONSTRUCCIONES Y AUXILIAR DE FERROCARRILES SA | June 14, 2025 | Reelect Julian Gracia Palacin as Director Director Elections |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CONTANGO ORE INC. | June 10, 2025 | Election of Directors: Richard A. Shortz Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 2 funds |
| CONTEMPORARY AMPEREX TECHNOLOGY CO. LTD. | December 26, 2024 | Elect Lin Xiaoxiong as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| CONVATEC GROUP PLC | May 22, 2025 | Approve Omnibus Incentive Plan Compensation |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| CONVATEC GROUP PLC | May 22, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 6 funds |
AGAINST 3 funds |
| COOPER-STANDARD HOLDINGS INC. | May 15, 2025 | Approval of the Cooper-Standard Holdings Inc. Amended and Restated 2021 Omnibus Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| CORBION NV | May 14, 2025 | Grant Board Authority to Issue Shares Up to 10 Percent of Issued Capital in Case of Mergers, Acquisitions, or Strategic Alliances Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| CORE & MAIN INC. | June 24, 2025 | Election of Directors: Dennis G. Gipson Director Elections |
Board | For | FOR 17 funds |
WITHHOLD 2 funds |
| COREM PROPERTY GROUP AB | August 14, 2024 | Approve Issuance of up to 10 Percent of Issued Shares without Preemptive Rights Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COREM PROPERTY GROUP AB | April 23, 2025 | APPROVE ISSUANCE OF UP TO 10 PERCENT OF ISSUED SHARES WITHOUT PREEMPTIVE RIGHTS Capital Structure |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| COREM PROPERTY GROUP AB | April 23, 2025 | REELECT PATRIK ESSEHORN AS BOARD CHAIR Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COREM PROPERTY GROUP AB | April 23, 2025 | REELECT PATRIK ESSEHORN AS DIRECTOR Corporate Governance |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| CORONATION FUND MANAGERS LTD. | February 18, 2025 | Approve Remuneration of Non-Executive Directors Compensation |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| CORONATION FUND MANAGERS LTD. | February 18, 2025 | Re-elect Hugo Nelson as Member of the Audit and Risk Committee Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| CORPORACION ACCIONA ENERGIAS RENOVABLES SA | June 5, 2025 | Advisory Vote on Remuneration Report Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CORSAIR GAMING INC. | June 10, 2025 | Election of three Class II Directors to serve until the 2028 annual meeting of stockholders or until their successors are elected: Anup Bagaria Director Elections |
Board | For | FOR 16 funds |
WITHHOLD 2 funds |
| COSCO SHIPPING PORTS LTD. | May 20, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| COSCO SHIPPING PORTS LTD. | May 20, 2025 | Authorize Reissuance of Repurchased Shares Capital Structure |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| COSCO SHIPPING PORTS LTD. | May 20, 2025 | Elect Wu Yu as Director Director Elections |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| COSMOS PHARMACEUTICAL CORP. | August 20, 2024 | Appoint Grant Thornton Taiyo LLC as New External Audit Firm Audit-related |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| COSTAMARE INC. | October 3, 2024 | Elect Director Vagn Lehd Moller Director Elections |
Board | For | FOR 8 funds |
AGAINST 2 funds |
| COUCHBASE INC. | May 29, 2025 | Election of Class I Directors: Lynn M. Christensen Director Elections |
Board | For | FOR 12 funds |
WITHHOLD 2 funds |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | May 23, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | May 23, 2025 | Authorize Reissuance of Repurchased Shares Capital Structure |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | May 23, 2025 | Elect Chen Weiru as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | May 23, 2025 | Elect Rui Meng as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COUNTRY GARDEN SERVICES HOLDINGS COMPANY LTD. | May 23, 2025 | Elect Yang Huiyan as Director Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| COVENANT LOGISTICS GROUP INC. | May 14, 2025 | To consider and act upon a proposal to elect nine (9) directors: Bradley A. Moline Director Elections |
Board | For | FOR 11 funds |
WITHHOLD 2 funds |
| CP ALL PUBLIC COMPANY LTD. | April 25, 2025 | Elect Dumrongsak Kittiprapas as Director Director Elections |
Board | For | FOR 5 funds |
AGAINST 2 funds |
| CPI EUROPE AG | May 20, 2025 | Approve Remuneration Report Compensation |
Board | For | AGAINST 7 funds |
FOR 2 funds |
| CREATE RESTAURANTS HOLDINGS INC. | May 28, 2025 | Elect Director Goto, Hitoshi Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| CREATE RESTAURANTS HOLDINGS INC. | May 28, 2025 | Elect Director Kawai, Jun Director Elections |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| CREATE SD HOLDINGS CO. LTD. | August 23, 2024 | Elect Director Yamamoto, Hisao Director Elections |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| CREATIVE MEDIA & COMMUNITY TRUST CORP. | August 1, 2024 | To consider and approve, by a non-binding advisory vote, the executive compensation for the fiscal year ended December 31, 2023, as disclosed in the proxy statement. Say-on-Pay |
Board | For | FOR 5 funds |
AGAINST 1 fund |
| CREDIT SAISON CO. LTD. | June 25, 2025 | Elect Director Mizuno, Katsumi Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| CREDIT SAISON CO. LTD. | June 25, 2025 | Elect Director Rinno, Hiroshi Director Elections |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| CREDITO EMILIANO SPA | April 30, 2025 | Approve Second Section of the Remuneration Report Compensation |
Board | For | AGAINST 6 funds |
FOR 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Jason Makler Director Elections |
Board | For | FOR 12 funds |
WITHHOLD 1 fund |
| CRICUT INC. | May 28, 2025 | Election of Directors: Steven Blasnik Director Elections |
Board | For | FOR 12 funds |
WITHHOLD 1 fund |
| CRICUT INC. | May 28, 2025 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 17 funds |
FOR 3 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.c Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026. Compensation |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.d Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025. Compensation |
Board | For | FOR 4 funds |
AGAINST 2 funds |
| CROSS COUNTRY HEALTHCARE INC. | February 28, 2025 | To approve on an advisory (non-binding) basis the compensation that may be paid or become payable to Cross Country's named executive officers that is based on or otherwise relates to the merger. Say-on-Pay |
Board | For | FOR 13 funds |
AGAINST 5 funds |
| CROWELL DEVELOPMENT CORP. | May 15, 2025 | Approve Issuance of Employee Stock Warrants Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| CRRC CORPORATION LTD. | June 18, 2025 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights for Additional A Shares and H Shares Capital Structure |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| CRYO-CELL INTERNATIONAL INC. | October 29, 2024 | Election of Directors: Daniel Mizrahi Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| CRYO-CELL INTERNATIONAL INC. | October 29, 2024 | Election of Directors: David Portnoy Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| CRYO-CELL INTERNATIONAL INC. | October 29, 2024 | Election of Directors: Mark Portnoy Director Elections |
Board | For | WITHHOLD 2 funds |
FOR 1 fund |
| CRYOPORT INC. | June 6, 2025 | To elect six directors: Ramkumar Mandalam, PhD Director Elections |
Board | For | FOR 9 funds |
WITHHOLD 2 funds |
| CSBC CORP. TAIWAN | June 25, 2025 | Amend Procedures for Endorsement and Guarantees Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSP INC. | February 4, 2025 | Election of Directors: Ismail "Izzy" Azeri Director Elections |
Board | For | FOR 4 funds |
WITHHOLD 1 fund |
| CSP INC. | February 4, 2025 | The approval of the 2025 CSP Inc. Stock Incentive Plan. Compensation |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Attribution of Profit and Loss During the Transition Period Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Audit Report, Pro Forma Review Report and Valuation Report in Relation to the Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Authorization of the Board and Its Authorized Persons to Handle All Related Matters Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Amount and Number of Issues Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Manner and Target Subscribers Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Issue Type, Par Value and Listing Location Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Lock-Up Period Arrangement Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Overall Plan Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Pricing Reference Date and Issue Price Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Report on the Usage of Previously Raised Funds Capital Structure |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Resolution Validity Period Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Target Assets Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
| CSPC INNOVATION PHARMACEUTICAL CO. LTD. | October 31, 2024 | Approve Transaction Parties Extraordinary Transactions |
Board | For | FOR 4 funds |
AGAINST 1 fund |
← Previous Page 19 of 58 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.